versão On-line ISSN 2078-5151
S. Afr. j. surg. vol.50 no.4 Cape Town Nov. 2012
R S EdlinI; C F HeynsII; S P J van VuurenIII; A D ZarrabiIII
IMD, BS. Department of Surgery, University of the Witwatersrand, Johannesburg
IIMB ChB, MMed (Urol), FCSSA (Urol), PhD. Department of Urology, Stellenbosch University and Tygerberg Hospital, Tygerberg, Western Cape
IIIMB ChB, MMed (Urol), FCUrol (SA). Department of Urology, Stellenbosch University and Tygerberg Hospital, Tygerberg, Western Cape
OBJECTIVE: To determine the prevalence of prostatitis on histopathological evaluation of prostatic tissue in men without urinary retention.
DESIGN, SETTING AND SUBJECTS: The clinical data and histopathology reports of men seen from January 1999 through March 2009 at our institution were analysed using Student's t-test, the Mann-Whitney test and Fisher's exact test where appropriate. Values were expressed as means, medians and ranges (p<0.05 accepted as statistically significant).
OUTCOME MEASURES: Data collected included patient age, duration of lower urinary tract symptoms and hospitalisation, findings on digital rectal examination, prostate volume, haemoglobin concentration, serum creatinine and prostate-specific antigen (PSA) levels, and histological findings.
RESULTS: Prostatic tissue of 385 men without urinary retention at presentation was obtained via biopsy (48.3% of cases), transurethral prostatectomy (62.9%), retropubic prostatectomy (6.8%) or radical prostatectomy (28.3%). On histological examination, benign prostatic hyperplasia (BPH) was found to be present in 213 patients (55.3%) and adenocarcinoma of the prostate (ACP) in 172 (44.7%). Histological prostatitis was present in 130 patients (61.0%) with BPH and 51 (29.7%) with ACP (p<0.001). A previous study of 405 men presenting with urinary retention at our institution showed histological prostatitis in 98/204 (48.0%) with BPH and in 51/201 (25.4%) with ACP. The group of men with BPH alone had a significantly lower mean serum PSA at presentation (4.5 ng/ml, range 0.3 - 20.8 ng/ml) compared with the group with BPH and prostatitis (11.2 ng/ml, range 0.2 - 145 ng/ml, p=0.011). The mean PSA level at presentation did not differ significantly between the group with ACP only (40.9 ng/ml, range 0 - 255 ng/ml) and the group with ACP plus prostatitis (1 672 ng/ml, range 0.3 - 38 169 ng/ml, p=0.076).
CONCLUSIONS: Among men presenting without urinary retention, histological prostatitis was significantly more prevalent in those with BPH than in those with ACP (61% v. 30%), similar to the previous study of men presenting with retention at our institution, in which histological prostatitis was significantly more prevalent in BPH than in ACP (48% v. 25%). This finding suggests that histological prostatitis is not significantly associated with the causation of ACP or urinary retention. Serum PSA at presentation was significantly higher in the group with BPH plus prostatitis compared with BPH alone, but not in the group with ACP plus prostatitis compared with ACP alone.
“Full text available only in PDF format”
1. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011;103:117-128. [http://dx.doi.org/10.1093/jnci/djq495] [ Links ]
2. Mishra VC, Allen DJ, Nicolaou C, et al. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia? BJU Int 2007;100:327-331. [http://dx.doi.org/10.1111/j.1464-410X.2007.06910.x] [ Links ]
3. Daniels NA, Ewing SK, Zmuda JM, Wilt TJ, Bauer DC. Correlates and prevalence of prostatitis in a large community-based cohort of older men. Urology 2005;66:964-970. [http://dx.doi.org/10.1016/j.urology.2005.05.034] [ Links ]
4. Sciarra A, Mariotti G, Salciccia S, et al. Prostate growth and inflammation. J Steroid Biochem Mol Biol 2008;108:254-260. [ Links ]
5. Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V. Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 2007;52:964-972. [http://dx.doi.org/10.1016/j.jsbmb.2007.09.013] [ Links ]
7. Van Vuuren SPJ, Heyns CF, Zarrabi AD. Significance of histological prostatitis in men with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate. BJU Int 2011;109:1194-1197. [http://dx.doi.org/10.1111/j.1464-410X.2011.10527] [ Links ]
10. Nelson WG, De Marzo AM, DeWeese TL, Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004;172:S6-S12. [http://dx.doi.org/10.1097/01.ju.0000142058.99614.ff] [ Links ]
12. Roberts RO, Bergstralh EJ, Bass SE, Lieber MM, Jacobsen SJ. Prostatitis as a risk factor for prostate cancer. Epidemiology 2004;15:93-99. [http://dx.doi.org/10.1097/01.ede.0000101022.38330.7c] [ Links ]
13. Asgari SA, Mohammadi M. The role of intraprostatic inflammation in the acute urinary retention. Int J Prev Med 2011;2:28-31. [ Links ]
14. Roehrborn CG. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE. BJU Int 2008;101 Suppl 3:17-21. [http://dx.doi.org/10.1111/j.1464-410X.2008.07497.x] [ Links ]
15. Irani J, Levillain P, Goujon JM, Bon D, Doré B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 1997;157:1301-1303. [http://dx.doi.org/10.1016/S0022-5347(01)64957-7] [ Links ]
16. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995;154:407-413. [ Links ]
17. Simardi LH, Tobias-Machado M, Kappaz GT, Taschner Goldenstein P, Potts JM, Wroclawski ER. Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: A prospective study. Urology 2004;64:1098-1101. [http://dx.doi.org/10.1016/j.urology.2004.08.060] [ Links ]
C F Heyns